IARC Monographs Volume 100A - Combined Estrogen–Progestogen Menopausal Therapy

Supplementary Web Tables, Section 2, Cancer in Humans

These web tables formed part of the original submission and have been peer reviewed. They are posted as supplied by the Working Group. Readers are requested to report any errors to: edit-vol100A@iarc.fr.
Table 2.1 Combined estrogen–progestogen menopausal therapy and breast cancer: consequences of the sequential regimen (sEPT) and the continuous combined regimen (ccEPT) (observational studies)
Table 2.2 Cohort studies of combined estrogen–progestogen menopausal therapy and breast cancer
Table 2.3 Case–control studies of combined estrogen–progestogen menopausal therapy and breast cancer
Table 2.4 Case–control studies of combined estrogen–progestogen menopausal therapy and endometrial cancer
Table 2.5 Cohort studies of combined estrogen–progestogen menopausal therapy and endometrial cancer
Table 2.6 Case–control studies of combined estrogen–progestogen menopausal therapy and colorectal cancer
Table 2.7 Cohort study of combined estrogen–progestogen menopausal therapy and colorectal cancer
Table 2.8 Case–control studies of combined estrogen–progestogen menopausal therapy and ovarian cancer
Table 2.9 Cohort studies of combined estrogen–progestogen menopausal therapy and ovarian cancer